Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Anixa Biosciences, Inc. (ANIX)

Pharmaceutical Preparations

https://www.anixa.com

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/12/1989

Market Cap

98,580,020

Shares Outstanding

31,700,000

Weighted SO

31,699,701

Total Employees

N/A

Upcoming Earnings

09/04/2024

Similar Tickers

CUE --.--%

INMB --.--%

INAB --.--%

PYPD --.--%

TFFP --.--%

IMNM --.--%

ANVS --.--%

AVTE --.--%

ADAG --.--%

Beta

0.8930

Last Div

0.0000

Range

2.15-5.13

Chg

-0.1100

Avg Vol

108522

Mkt Cap

98580020

Exch

NASDAQ

Country

US

Phone

408 708 9808

DCF Diff

3.0838

DCF

0.0068

Div Yield

0.0000

P/S

631.9232

EV Multiple

-7.5628

P/FV

4.1610

Div Yield %

0.0000

P/E

-8.4774

PEG

-0.3108

Payout

0.0000

Current Ratio

14.4045

Quick Ratio

14.4045

Cash Ratio

0.5919

DSO

510.0641

DIO

0.0000

Op Cycle

510.0641

DPO

1634.8958

CCC

-1124.8317

Gross Margin

0.6923

Op Margin

-83.1474

Pretax Margin

-75.2500

Net Margin

-74.3269

Eff Tax Rate

0.0123

ROA

-0.4761

ROE

-0.4729

ROCE

-0.5721

NI/EBT

0.9877

EBT/EBIT

0.9050

EBIT/Rev

-83.1474

Debt Ratio

0.0061

D/E

0.0063

LT Debt/Cap

0.0039

Total Debt/Cap

0.0063

Int Coverage

-254.3333

CF/Debt

-48.1812

Equity Multi

1.0310

Rec Turnover

0.7156

Pay Turnover

0.2233

Inv Turnover

0.0000

FA Turnover

1.1064

Asset Turnover

0.0064

OCF/Share

-0.2249

FCF/Share

-0.2249

Cash/Share

0.7282

OCF/Sales

-46.0192

FCF/OCF

1.0000

CF Coverage

-48.1812

ST Coverage

-128.1964

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

4.1610

P/B

4.1610

P/S

631.9232

P/E

-8.4774

P/FCF

-13.7317

P/OCF

-13.6920

P/CF

-13.6920

PEG

-0.3108

P/S

631.9232

EV Multiple

-7.5628

P/FV

4.1610

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation